Is AI the Future of Clinical Trials? - Digital Health Central

Clinical Trials are the mandatory path for developing and bringing a new drug or vaccine to the market. Unfortunately, according to a study conducted by MIT, 86 percent of the drugs will fail during this process. This very high failure rate not only has consequences on the Pharmaceutical companies' bottom line, but it precludes potentially safe and efficacious drugs from reaching patients that could benefit from them. Recruitment is one of the main bottlenecks, is time-consuming, and very expensive. According to Chunhua Weng from Columbia University (New York), "Recruitment is the number one barrier to clinical research."